Citation

  • Authors: Ni, J. S., Zheng, H., Huang, Z. P., Hong, Y. G., Ou, Y. L., Tao, Y. P., Wang, M. C., Wang, Z. G., Yang, Y., Zhou, W. P.
  • Year: 2019
  • Journal: Oncol Lett 17 2317-2327
  • Applications: in vitro / antimiR, mimic miRNA / jetPRIME
  • Cell type: HCCLM3
    Description: Human hepatocellular carcinoma
    Known as: LM3 ; MHCC-LM3 ; MHCCLM3

Method

5 µg oligo/well in 6-well plate

Abstract

MicroRNAs (miRNAs) serve an important regulatory role in carcinogenesis and cancer progression. Aberrant expression of miR-197-3p has been reported in various human malignancies. However, the role of miR-197-3p in the progression and prognosis of hepatocellular carcinoma (HCC) remains unknown. The present study demonstrated that miR-197-3p was downregulated in HCC tissues and that the low level of miR-197-3p expression in HCC tumours correlated with aggressive clinicopathological characteristics; thus, miR-197-3p may serve as a predictor for poor prognosis in patients with HCC. Additionally, miR-197-3p markedly inhibited the metastasis of HCC cells in vitro and in vivo. Bioinformatics analysis further identified zinc finger protein interacted with K protein 1 (ZIK1) as a novel target of miR-197-3p in HCC cells. These findings suggest that miR-197-3p may regulate the survival of HCC cells, partially through the downregulation of ZIK1. Therefore, the miR-197-3p/ZIK1 axis may serve as a novel therapeutic target in patients with HCC.

Go to